| Literature DB >> 36258005 |
Lunzhi Yuan1, Huachen Zhu2,3,4, Peiwen Chen2,3,4, Ming Zhou1, Jian Ma1, Xuan Liu1, Kun Wu1, Rirong Chen2,3,4, Qiwei Liu2,3,4, Huan Yu2,3,4, Lifeng Li2,3,4, Jia Wang2,3,4, Yali Zhang1, Shengxiang Ge1, Quan Yuan1, Qiyi Tang5, Tong Cheng6, Yi Guan7,8,9, Ningshao Xia10.
Abstract
The new predominant circulating SARS-CoV-2 variant, Omicron, can robustly escape current vaccines and neutralizing antibodies. Although Omicron has been reported to have milder replication and disease manifestations than some earlier variants, its pathogenicity in different age groups has not been well elucidated. Here, we report that the SARS-CoV-2 Omicron BA.1 sublineage causes elevated infection and lung pathogenesis in juvenile and aged hamsters, with more body weight loss, respiratory tract viral burden, and lung injury in these hamsters than in adult hamsters. Juvenile hamsters show a reduced interferon response against Omicron BA.1 infection, whereas aged hamsters show excessive proinflammatory cytokine expression, delayed viral clearance, and aggravated lung injury. Early inhaled IFN-α2b treatment suppresses Omicron BA.1 infection and lung pathogenesis in juvenile and adult hamsters. Overall, the data suggest that the diverse patterns of the innate immune response affect the disease outcomes of Omicron BA.1 infection in different age groups.Entities:
Keywords: Innate immune response; Interferon treatment; Lung pathology; SARS-CoV-2 Omicron
Year: 2022 PMID: 36258005 PMCID: PMC9579545 DOI: 10.1038/s41423-022-00923-9
Source DB: PubMed Journal: Cell Mol Immunol ISSN: 1672-7681 Impact factor: 22.096